drugset / Trial / NCT07116239
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
Not yet recruiting
60 enrolled
Peking University People's Hospital
Chinese Academy of Medical Sciences, Fuwai Hospital · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
A study to evaluate the impact of nephrotic syndrome on the steady state pharmacokinetics and pharmacodynamics of edoxaban compared to health volunteers, and whether edoxaban can provide an equivalent anticoagulant effect to enoxaparin sodium.
Timeline
- Start
- 2025-09
- Primary completion
- 2026-02
- Completion
- 2026-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edoxaban | Small molecule | 60 mg | Oral |
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |